The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors.
Wheeler CE, Coleman SS 4th, Hoyd R, Denko L, Chan CHF, Churchman ML, Denko N, Dodd RD, Eljilany I, Hardikar S, Husain M, Ikeguchi AP, Jin N, Ma Q, McCarter MD, Osman AEG, Robinson LA, Singer EA, Tinoco G, Ulrich CM, Zakharia Y, Spakowicz D, Tarhini AA, Tan AC.
Wheeler CE, et al. Among authors: ulrich cm.
bioRxiv [Preprint]. 2023 May 25:2023.05.24.542123. doi: 10.1101/2023.05.24.542123.
bioRxiv. 2023.
PMID: 37292921
Free PMC article.
Updated.
Preprint.